| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |